RSS-Feed abonnieren
DOI: 10.5999/aps.2021.00493
The grey zone in plastic surgery: priorities amidst the COVID 19 pandemic
Introduction
The coronavirus disease 2019 (COVID-19) outbreak originated in Wuhan, China in December 2019. It soon spread beyond China, ravaging other nations, and was declared a pandemic by the World Health Organization (WHO) on March 11, 2020 [1]. The sheer number of COVID-19 cases forced hospitals across the world to make major adjustments in their day-to-day activities. Like all other surgical branches, the COVID-19 pandemic has also affected the specialty of plastic surgery. Following the guidelines given by the American Society of Plastic Surgeons, plastic surgeons in the United States stopped performing elective and non-emergent procedures [2]. Only in a few countries (e.g., England, Ireland, and Sweden) were there no legal restrictions on performing elective plastic surgery procedures [3]. Plastic surgery encompasses a vast array of surgical procedures that cannot be just classified under just two headings, as emergent or non-emergent. There is a third variety of cases that can be classified as “essential”—that is, procedures that cannot be classified as emergency procedures but still cannot be delayed. We present a guideline in this article to identify patients who require such “essential” surgical procedures.
The emergency procedures mentioned in the literature as deserving immediate action include replantation of amputated limbs/digits, reconstruction of defects involving the skull base, third-degree burns and major burns, high-risk malignancies, and fasciotomy for compartment syndrome [4].
Publikationsverlauf
Eingereicht: 24. Februar 2021
Angenommen: 27. Mai 2021
Artikel online veröffentlicht:
19. März 2022
© . The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
REFERENCES
- 1 World Health Organization (WHO). Coronavirus disease 2019 (COVID2019): situation report 51 [Internet]. Geneva: WHO; c2020 [2020 Jun 25]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10
- 2 American Society of Plastic Surgeons (ASPS). ASPS Guidance Regarding Elective and Non-Essential Patient Care [Internet]. Arlington Heights, IL: ASPS; c2020 [2020 Jun 25]. Available from: http://email.plasticsurgery.org/q/12EC50dbrptNnCCaBimf8m0W/wv
- 3 Giunta RE, Frank K, Costa H. et al. The COVID-19 pandemic and its impact on plastic surgery in Europe: an ESPRAS survey. Handchir Mikrochir Plast Chir 2020; 52: 221-2
- 4 Kaye K, Paprottka F, Escudero R. et al. Elective, non-urgent procedures and aesthetic surgery in the wake of SARS-COVID-19: considerations regarding safety, feasibility and impact on clinical management. Aesthetic Plast Surg 2020; 44: 1014-42
- 5 van Aalst JA, Kolappa KK, Sadove M. MOC-PSSM CME article: nonsyndromic cleft palate. Plast Reconstr Surg 2008; 121(1 Suppl): 1-14
- 6 World Health Organization (WHO). Disability and health [Internet]. Geneva: WHO; c2020 [2020 Jun 25]. Available from: https://www.who.int/news-room/fact-sheets/detail/disability-and-health